细胞株Cell Lines 32-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
- 价 格：¥19200
- 货 号：Cell Line CV32
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
Email:biovector@163.com
ID He We
AC CVCL_0611
DR CLO; CLO_0003673
DR ATCC; CRL-1338
DI NCIt; C118636; Stiff skin syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE-1
AC CVCL_2922
DR BioSample; SAMN03472777
DR IFO; IFO50297
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 10,13
ST D7S820: 10
ST TH01: 8,9
ST TPOX: 8,9
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HE-209
AC CVCL_6E85
RX PubMed=2423124;
RX PubMed=6187748;
CC Characteristics: Has a different growth rate at the permissive temperature (33 Celsius) than at the restrictive temperature (40 Celsius).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA209].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6E86 ! HE-SV
SX Male
CA Transformed cell line
//
ID HE-LU (Rifkin)
AC CVCL_3698
SY HE-LU(Rifkin)
DR CLO; CLO_0003700
DR ATCC; CRL-7717
DR BioSample; SAMN03471141
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7717; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HE-SK
AC CVCL_3699
DR CLO; CLO_0003717
DR ATCC; CRL-7718
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7718; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HE-SV
AC CVCL_6E86
RX PubMed=2423124;
RX PubMed=6187748;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6E85 ! HE-209
SX Male
CA Transformed cell line
//
ID HE12
AC CVCL_0T75
DR CLO; CLO_0050435
DR BioSample; SAMN03472030
DR RCB; RCB2233
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 8
ST D16S539: 9
ST D5S818: 13
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE13
AC CVCL_0T76
DR CLO; CLO_0050436
DR BioSample; SAMN03472031
DR RCB; RCB2234
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8
ST D16S539: 10,11
ST D5S818: 10,11
ST D7S820: 9,11
ST TH01: 7
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE16
AC CVCL_0T77
DR CLO; CLO_0050437
DR BioSample; SAMN03472032
DR RCB; RCB2237
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,13
ST D16S539: 10,12
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 6,9
ST TPOX: 8,10
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE18
AC CVCL_0T78
DR CLO; CLO_0050438
DR BioSample; SAMN03472033
DR RCB; RCB2238
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE19
AC CVCL_0T79
DR CLO; CLO_0050439
DR BioSample; SAMN03471974
DR RCB; RCB2239
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE21
AC CVCL_0T80
DR CLO; CLO_0050440
DR BioSample; SAMN03471975
DR RCB; RCB2240
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 9,10
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE22
AC CVCL_0T81
DR CLO; CLO_0050441
DR BioSample; SAMN03471977
DR RCB; RCB2241
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 10
ST D5S818: 10
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE23
AC CVCL_H257
RX PubMed=9610031;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE27
AC CVCL_0T82
DR CLO; CLO_0050442
DR BioSample; SAMN03471978
DR RCB; RCB2244
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 8
ST TH01: 6,7
ST TPOX: 11,12
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE28
AC CVCL_0T83
DR CLO; CLO_0050443
DR BioSample; SAMN03471979
DR RCB; RCB2245
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 9,10
ST D5S818: 10,11
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE29
AC CVCL_0T84
DR CLO; CLO_0050444
DR BioSample; SAMN03471980
DR RCB; RCB2246
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8
ST D16S539: 11
ST D5S818: 9,11
ST D7S820: 11
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE30
AC CVCL_0T85
DR CLO; CLO_0050445
DR BioSample; SAMN03471981
DR RCB; RCB2247
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 9,12
ST D5S818: 11,14
ST D7S820: 8,12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE31
AC CVCL_H258
DR CLO; CLO_0050446
DR BioSample; SAMN03471982
DR RCB; RCB2248
RX PubMed=9610031;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 9,11
ST D5S818: 10,11
ST D7S820: 8,10
ST TH01: 6,9
ST TPOX: 9,11
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE32
AC CVCL_0T86
DR CLO; CLO_0050447
DR BioSample; SAMN03471983
DR RCB; RCB2249
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 10,13
ST D5S818: 10,13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE33
AC CVCL_0T87
DR CLO; CLO_0050448
DR BioSample; SAMN03471984
DR RCB; RCB2250
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE34
AC CVCL_0T88
DR CLO; CLO_0050449
DR BioSample; SAMN03471985
DR RCB; RCB2251
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE36
AC CVCL_0T89
DR CLO; CLO_0050450
DR BioSample; SAMN03471989
DR RCB; RCB2254
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 8,12
ST TH01: 6,9
ST TPOX: 9
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE37
AC CVCL_0T90
DR CLO; CLO_0050451
DR RCB; RCB2256
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE38
AC CVCL_0T91
DR CLO; CLO_0050452
DR BioSample; SAMN03471990
DR RCB; RCB2257
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 7,12
ST D13S317: 11,13
ST D16S539: 11,12
ST D5S818: 9,10
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE39
AC CVCL_0T92
DR CLO; CLO_0050453
DR BioSample; SAMN03471991
DR RCB; RCB2258
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 11,13
ST D5S818: 12,15
ST D7S820: 11,13
ST TH01: 6,9
ST TPOX: 9,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE40
AC CVCL_H259
DR CLO; CLO_0050454
DR BioSample; SAMN03471992
DR RCB; RCB2259
RX PubMed=9610031;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 8,10
ST TH01: 8,9
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE41
AC CVCL_0T93
DR CLO; CLO_0050456
DR BioSample; SAMN03471993
DR RCB; RCB2260
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE42
AC CVCL_0T94
DR CLO; CLO_0050457
DR BioSample; SAMN03471994
DR RCB; RCB2261
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 6,7
ST TPOX: 11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE46
AC CVCL_0T95
DR CLO; CLO_0050455
DR BioSample; SAMN03471995
DR RCB; RCB2262
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 8,9
ST D16S539: 9,11
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE47
AC CVCL_0T96
DR CLO; CLO_0050458
DR BioSample; SAMN03471996
DR RCB; RCB2263
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE48
AC CVCL_0T97
DR CLO; CLO_0050459
DR BioSample; SAMN03471997
DR RCB; RCB2264
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 12,13
ST D7S820: 8,9
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 14,20
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE49
AC CVCL_0T98
DR CLO; CLO_0050460
DR BioSample; SAMN03471998
DR RCB; RCB2265
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,10
ST D16S539: 10
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 8,9
ST TPOX: 10,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE50
AC CVCL_0T99
DR CLO; CLO_0050466
DR BioSample; SAMN03472000
DR RCB; RCB2266
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,12
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 8,9
ST TH01: 9
ST TPOX: 8,9
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE51
AC CVCL_0U00
DR CLO; CLO_0050461
DR BioSample; SAMN03472001
DR RCB; RCB2267
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 10,12
ST TH01: 6,8
ST TPOX: 8
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE52
AC CVCL_0U01
DR CLO; CLO_0050462
DR BioSample; SAMN03472002
DR RCB; RCB2268
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 12
ST D5S818: 9,13
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 11,12
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE53
AC CVCL_0U02
DR CLO; CLO_0050463
DR BioSample; SAMN03472003
DR RCB; RCB2269
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 9,10
ST D5S818: 9,10
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE54
AC CVCL_0U03
DR CLO; CLO_0050467
DR BioSample; SAMN03471944
DR RCB; RCB2270
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 9,13
ST D5S818: 11,13
ST D7S820: 9,11
ST TH01: 7
ST TPOX: 8,9
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HE55
AC CVCL_0U04
DR CLO; CLO_0050464
DR BioSample; SAMN03471945
DR RCB; RCB2271
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 8
ST D16S539: 9
ST D5S818: 12
ST D7S820: 10
ST TH01: 6,9
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HE57
AC CVCL_0U05
DR CLO; CLO_0050465
DR BioSample; SAMN03471946
DR RCB; RCB2273
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8,10
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HeB5
AC CVCL_S549
DR ECACC; 11033104
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: C57L.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0328 ! Hepa-1c1c7
SX Female
CA Cancer cell line
//
ID HEC
AC CVCL_N814
DR Cosmic; 735332
DR Cosmic; 1656050
RX PubMed=15274292;
RX PubMed=22426987;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HEC-1
AC CVCL_1274
SY HEC1; Human Endometrial Cancer-1
DR BioSample; SAMN03472810
DR ChEMBL-Cells; CHEMBL3308740
DR ChEMBL-Targets; CHEMBL1075462
DR Cosmic; 907051
DR Cosmic-CLP; 907051
DR GDSC; 907051
DR GEO; GSM827285
DR GEO; GSM1669873
DR JCRB; JCRB0042
DR LINCS; 50014
RX PubMed=4673779;
RX PubMed=4678779;
RX PubMed=9290701;
RX PubMed=12227503;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,16 (Cosmic-CLP)
ST D13S317: 11 (JCRB)
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 11
ST vWA: 18
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HEC-1-A
AC CVCL_0293
SY Hec-1-A; HEC-1A; HEC1-A; HEC1A; Hec1A
DR BTO; BTO:0002960
DR CLO; CLO_0003674
DR EFO; EFO_0002191
DR MCCL; MCC:0000183
DR ATCC; HTB-112
DR BCRC; 60552
DR BioSample; SAMN03471093
DR BioSample; SAMN03472456
DR CCLE; HEC1A_ENDOMETRIUM
DR CCRID; 3131C0001000700149
DR Cosmic; 713474
DR Cosmic; 713494
DR Cosmic; 724853
DR Cosmic; 809130
DR Cosmic; 846177
DR Cosmic; 871552
DR Cosmic; 889115
DR Cosmic; 1007160
DR Cosmic; 1066222
DR Cosmic; 1177620
DR Cosmic; 1177685
DR Cosmic; 1576457
DR Cosmic; 1594188
DR Cosmic; 1622896
DR Cosmic; 2030464
DR Cosmic; 2301550
DR Cosmic; 2464665
DR GEO; GSM844555
DR GEO; GSM844556
DR GEO; GSM887069
DR GEO; GSM888139
DR IGRhCellID; HEC1A
DR JCRB; JCRB1117
DR JCRB; NIHS0388
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=7459858;
RX PubMed=12227503;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=28196595;
WW http://www.identicell.eu/files/Sample-IdentiCell-report.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC Doubling time: 27 hours (PubMed=25984343).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0388; true.
ST Source(s): ATCC; IdentiCell; JCRB
ST Amelogenin: X
ST CSF1PO: 10,12 (ATCC; IdentiCell)
ST CSF1PO: 10,13,14 (JCRB)
ST D13S317: 11,12 (ATCC)
ST D13S317: 9,11,14 (IdentiCell)
ST D13S317: 11 (JCRB)
ST D16S539: 12,13 (ATCC; JCRB)
ST D16S539: 12 (IdentiCell)
ST D21S11: 30,31
ST D5S818: 11,14,15 (ATCC)
ST D5S818: 11,15 (IdentiCell; JCRB)
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 8,11 (ATCC; IdentiCell)
ST TPOX: 8,9,11 (JCRB)
ST vWA: 18,19 (ATCC)
ST vWA: 18,19,20 (IdentiCell)
ST vWA: 19,20,22 (JCRB)
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1274 ! HEC-1
SX Female
CA Cancer cell line
//
ID HEC-1-A-OZA1
AC CVCL_AR90
DR BioSample; SAMN03472374
DR JCRB; NIHS0388.1
CC Discontinued: JCRB; NIHS0388.1; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11,13
ST D16S539: 13
ST D5S818: 11,13,16
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 19,24
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0293 ! HEC-1-A
SX Female
CA Cancer cell line
//
ID HEC-1-A-OZA2
AC CVCL_AR91
DR BioSample; SAMN03472376
DR JCRB; NIHS0388.2
CC Discontinued: JCRB; NIHS0388.2; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11,13
ST D16S539: 12,13
ST D5S818: 11,12,16
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 19,24
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0293 ! HEC-1-A
SX Female
CA Cancer cell line
//
ID HEC-1-A-OZA3
AC CVCL_AR92
DR BioSample; SAMN03472377
DR JCRB; NIHS0388.3
CC Discontinued: JCRB; NIHS0388.3; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11,13
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,15
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 19,22
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0293 ! HEC-1-A
SX Female
CA Cancer cell line
//
ID HEC-1-A-OZA4
AC CVCL_AR93
DR BioSample; SAMN03472378
DR JCRB; NIHS0388.4
CC Discontinued: JCRB; NIHS0388.4; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,15
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 19,22
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0293 ! HEC-1-A
SX Female
CA Cancer cell line
//
ID HEC-1-A-OZA5
AC CVCL_AR94
DR BioSample; SAMN03472379
DR JCRB; NIHS0388.5
CC Discontinued: JCRB; NIHS0388.5; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11,12,15
ST D16S539: 12,13
ST D5S818: 11,12,16
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 19,24
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0293 ! HEC-1-A
SX Female
CA Cancer cell line
//
ID HEC-1-A-OZA6
AC CVCL_AR95
DR BioSample; SAMN03472380
DR JCRB; NIHS0388.6
CC Discontinued: JCRB; NIHS0388.6; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11,14
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,15
ST D7S820: 9,11
ST TH01: 6,7,8
ST TPOX: 8,11
ST vWA: 19,25
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0293 ! HEC-1-A
SX Female
CA Cancer cell line
//
ID HEC-1-B
AC CVCL_0294
SY Hec-1-B; HEC-1B; HEC1-B; HEC1B; Hec1B
DR BTO; BTO:0003038
DR CLO; CLO_0003675
DR EFO; EFO_0002192
DR MCCL; MCC:0000184
DR CLDB; cl1582
DR ATCC; HTB-113
DR BioSample; SAMN03471094
DR BioSample; SAMN03472427
DR BioSample; SAMN03473077
DR CCLE; HEC1B_ENDOMETRIUM
DR CCRID; 3111C0001CCC000105
DR CCRID; 3131C0001000700115
DR CCRID; 3142C0001000000100
DR ChEMBL-Cells; CHEMBL3308662
DR ChEMBL-Targets; CHEMBL614817
DR Cosmic; 687552
DR Cosmic; 809131
DR Cosmic; 846178
DR Cosmic; 980635
DR Cosmic; 1070807
DR Cosmic; 1177621
DR Cosmic; 1223486
DR Cosmic; 1241345
DR Cosmic; 1576458
DR Cosmic; 1696757
DR Cosmic; 2030465
DR GEO; GSM844557
DR GEO; GSM887070
DR GEO; GSM888140
DR IGRhCellID; HEC1B
DR JCRB; JCRB1193
DR JCRB; NIHS0480
DR KCB; KCB 200551YJ
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6163305;
RX PubMed=6174649;
RX PubMed=12227503;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0480; true.
ST Source(s): ATCC; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,16 (ATCC)
ST D13S317: 11 (JCRB; PubMed=25877200)
ST D16S539: 11,12
ST D18S51: 16,20
ST D21S11: 30,31
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 9,11
ST D8S1179: 13,14
ST FGA: 21
ST Penta D: 9,13
ST Penta E: 11
ST TH01: 6,7 (ATCC; JCRB)
ST TH01: 6 (PubMed=25877200)
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0293 ! HEC-1-A
SX Female
CA Cancer cell line
//
ID HEC-108
AC CVCL_2923
SY HEC108
DR BioSample; SAMN03470971
DR BioSample; SAMN03472459
DR CCLE; HEC108_ENDOMETRIUM
DR Cosmic; 1223494
DR Cosmic; 1241342
DR Cosmic; 1696755
DR Cosmic; 2030466
DR GEO; GSM887067
DR GEO; GSM888137
DR JCRB; JCRB1123
DR JCRB; NIHS0394
RX DOI=10.5795/jjscc.26.433;
RX PubMed=22460905;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0394; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,10,11 (JCRB)
ST D13S317: 9,10,11,12,13 (PubMed=25877200)
ST D16S539: 12,13 (JCRB)
ST D16S539: 11,12,13 (PubMed=25877200)
ST D18S51: 11,12,13
ST D19S433: 11.2,12.2,14.2,15.2,16.2
ST D21S11: 29,30,31
ST D2S1338: 16,17,19,20
ST D3S1358: 15,16,17
ST D5S818: 6,12 (JCRB)
ST D5S818: 12 (PubMed=25877200)
ST D7S820: 8,9,12
ST D8S1179: 11,13
ST FGA: 22,23
ST Penta D: 8,9,10
ST Penta E: 15,19,20
ST TH01: 8,9
ST TPOX: 11,12 (JCRB)
ST TPOX: 11 (PubMed=25877200)
ST vWA: 15,16,17
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HEC-116
AC CVCL_2924
SY HEC116
DR BioSample; SAMN03470936
DR Cosmic; 1223495
DR Cosmic; 1696748
DR Cosmic; 2030467
DR JCRB; JCRB1124
DR JCRB; NIHS0395
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Discontinued: JCRB; NIHS0395; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,11
ST D16S539: 9
ST D18S51: 17,25
ST D19S433: 14,16.2
ST D21S11: 29
ST D2S1338: 20,21
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 14
ST FGA: 23,25
ST Penta D: 12,13
ST Penta E: 14,18
ST TH01: 6,8
ST TPOX: 11
ST vWA: 20
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HEC-151
AC CVCL_2925
SY HEC151
DR BioSample; SAMN03470938
DR CCLE; HEC151_ENDOMETRIUM
DR Cosmic; 1696754
DR Cosmic; 2030468
DR GEO; GSM887068
DR GEO; GSM888138
DR JCRB; JCRB1122
DR JCRB; NIHS0396
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0396; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 7,11
ST D13S317: 8,13,14
ST D16S539: 9,11
ST D18S51: 13,23,24
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 19,20,24
ST D3S1358: 14,15
ST D5S818: 10,13,14
ST D7S820: 8,11
ST D8S1179: 12,13
ST FGA: 19.1,22,23,24
ST Penta D: 8.4,9,10
ST Penta E: 13,14,19
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,19
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HEC-155
AC CVCL_2926
DR BioSample; SAMN03151656
DR BioSample; SAMN03472460
DR JCRB; JCRB1127
DR JCRB; NIHS0397
RX PubMed=15285295;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. HEC-155 and HEC-180 have been shown to be idnetical (PubMed=20143388).
CC Discontinued: JCRB; JCRB1127; true.
CC Discontinued: JCRB; NIHS0397; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,13,14
ST D13S317: 8
ST D16S539: 12
ST D5S818: 10,11
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 9,12
ST vWA: 14
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8313 ! HEC-180
SX Female
CA Cancer cell line
//
ID HEC-180
AC CVCL_8313
DR BioSample; SAMN03151655
DR JCRB; JCRB1144
DR JCRB; NIHS0398
RX PubMed=15285295;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. HEC-155 and HEC-180 have been shown to be idnetical (PubMed=20143388).
CC Discontinued: JCRB; JCRB1144; true.
CC Discontinued: JCRB; NIHS0398; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,13,14
ST D13S317: 8
ST D16S539: 12
ST D5S818: 10,11
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 9,12
ST vWA: 14
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2926 ! HEC-155
SX Female
CA Cancer cell line
//
ID HEC-1C
AC CVCL_S835
SY HEC-1 C; HEC-IC
RX PubMed=6299971;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1274 ! HEC-1
SX Female
CA Cancer cell line
//
ID HEC-1D
AC CVCL_S836
SY HEC-1 D; HEC-ID
RX PubMed=6299971;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1274 ! HEC-1
SX Female
CA Cancer cell line
//
ID HEC-251
AC CVCL_2927
SY HEC251
DR BioSample; SAMD00048820
DR BioSample; SAMN03470931
DR CCLE; HEC251_ENDOMETRIUM
DR Cosmic; 2030469
DR GEO; GSM887071
DR GEO; GSM888141
DR JCRB; JCRB1141
RX PubMed=15171304;
RX PubMed=22460905;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 11
ST D16S539: 9
ST D18S51: 13,20
ST D19S433: 14,15
ST D21S11: 30,31.2
ST D2S1338: 16,19
ST D3S1358: 15,16
ST D5S818: 9,12
ST D7S820: 11
ST D8S1179: 10,13
ST FGA: 20,21
ST Penta D: 9,10
ST Penta E: 5,15
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HEC-265
AC CVCL_2928
SY HEC265
DR BioSample; SAMD00048821
DR BioSample; SAMN03470883
DR CCLE; HEC265_ENDOMETRIUM
DR Cosmic; 2030470
DR GEO; GSM887072
DR GEO; GSM888142
DR JCRB; JCRB1142
DR JCRB; NIHS0400
RX PubMed=15171304;
RX PubMed=22460905;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0400; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 15,18
ST D19S433: 14,16.2
ST D21S11: 30
ST D2S1338: 22,24
ST D3S1358: 14,15
ST D5S818: 10,12
ST D7S820: 10,11
ST D8S1179: 14,15,16
ST FGA: 20,22,23
ST Penta D: 9
ST Penta E: 14,16
ST TH01: 9
ST TPOX: 9,11
ST vWA: 19,22
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HEC-46
AC CVCL_T734
SY HEC-46R1; HEC46
DR JCRB; NIHS0258
RX PubMed=8242641;
CC Discontinued: JCRB; NIHS0258; true.
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HEC-50B
AC CVCL_2929
SY HEC50B; HEC-50; HEC50; Hec50
DR BioSample; SAMN03470885
DR CCLE; HEC50B_ENDOMETRIUM
DR Cosmic; 1223491
DR Cosmic; 1576459
DR Cosmic; 1696760
DR Cosmic; 2030471
DR GEO; GSM887073
DR GEO; GSM888143
DR JCRB; JCRB1145
DR JCRB; NIHS0391
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0391; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9
ST D16S539: 12
ST D18S51: 14
ST D19S433: 13
ST D21S11: 30,31
ST D2S1338: 23
ST D3S1358: 15,16
ST D5S818: 8
ST D7S820: 12
ST D8S1179: 10,15
ST FGA: 20
ST Penta D: 10
ST Penta E: 5
ST TH01: 9
ST TPOX: 9
ST vWA: 14
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HEC-59
AC CVCL_2930
SY HEC59; Hec59
DR BioSample; SAMN03472458
DR BioSample; SAMN03470882
DR CCLE; HEC59_ENDOMETRIUM
DR Cosmic; 1070806
DR Cosmic; 1223492
DR Cosmic; 1576460
DR Cosmic; 1622901
DR Cosmic; 1696750
DR Cosmic; 2030472
DR GEO; GSM887074
DR GEO; GSM888144
DR JCRB; JCRB1120
DR JCRB; NIHS0392
RX DOI=10.5795/jjscc.26.433;
RX PubMed=9000572;
RX PubMed=12227503;
RX PubMed=22460905;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=42
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0392; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 9,10,11
ST D16S539: 11,12,13
ST D18S51: 12,13
ST D19S433: 12,13
ST D21S11: 29,32
ST D2S1338: 15,16
ST D3S1358: 13,14,16,17
ST D5S818: 10,11,12
ST D7S820: 10,11,14
ST D8S1179: 12,15
ST FGA: 21,22,23
ST Penta D: 9,10,11
ST Penta E: 15,16
ST TH01: 7,9.3
ST TPOX: 11,14 (JCRB)
ST TPOX: 11 (PubMed=25877200)
ST vWA: 17,20,22
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HEC-6
AC CVCL_2931
SY HEC6
DR BioSample; SAMN03470939
DR BioSample; SAMN03472457
DR CCLE; HEC6_ENDOMETRIUM
DR Cosmic; 1223490
DR Cosmic; 1696749
DR Cosmic; 2030473
DR GEO; GSM887075
DR GEO; GSM888145
DR JCRB; JCRB1118
DR JCRB; NIHS0390
RX PubMed=862644;
RX PubMed=22460905;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0390; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,10,13
ST D13S317: 11,12
ST D16S539: 8,10
ST D18S51: 12,13
ST D19S433: 14
ST D21S11: 27.2,29
ST D2S1338: 21,23
ST D3S1358: 16,17
ST D5S818: 13,14,15
ST D7S820: 8,9,11 (JCRB)
ST D7S820: 8,9,11,12 (PubMed=25877200)
ST D8S1179: 9,10,12
ST FGA: 20,21,22
ST Penta D: 10
ST Penta E: 14,15,17
ST TH01: 6,9,10 (JCRB)
ST TH01: 6,10 (PubMed=25877200)
ST TPOX: 8,9,10
ST vWA: 16,18
DI NCIt; C6290; Endometrial endometrioid adenocarcinoma, variant with squamous differentiation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HEC-88nu
AC CVCL_2932
SY HEC-88 nu; HEC88nu; HEC88NU; HEC-88
DR BioSample; SAMN03470941
DR Cosmic; 1223493
DR Cosmic; 1696751
DR JCRB; JCRB1121
DR JCRB; NIHS0393
RX DOI=10.5795/jjscc.26.433;
RX PubMed=12227503;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Discontinued: JCRB; NIHS0393; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 8,13
ST D16S539: 11
ST D18S51: 14,16,17
ST D19S433: 13
ST D21S11: 29,31.2
ST D2S1338: 19,23
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 13,16
ST FGA: 21,22
ST Penta D: 9,12
ST Penta E: 5,15
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hec50Co
AC CVCL_4Y59
SY HEC-50CO
DR Cosmic; 1393157
RX PubMed=11830547;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2929 ! HEC-50B
SX Female
CA Cancer cell line
//
ID HECA-452
AC CVCL_4577
DR CLO; CLO_0003676
DR ATCC; HB-11485
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID HECV
AC CVCL_0295
DR CLO; CLO_0003677
DR MCCL; MCC:0000185
DR CLDB; cl5543
DR ICLC; HL01001
ST Source(s): ICLC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D21S11: 29
ST D5S818: 10
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HEEM
AC CVCL_M603
RX PubMed=857824;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HEFX
AC CVCL_9837
SY HEFX1; HUJIe001-A
DR hPSCreg; HUJIe001-A
DR ISCR; 1766
RX PubMed=18371394;
CC From: Hebrew University; Jerusalem; Israel.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HEI-OC1
AC CVCL_D899
SY HEIOC1; House Ear Institute-Organ of Corti 1
DR BTO; BTO:0004862
DR Wikidata; Q27653205
RX PubMed=12811000;
RX PubMed=26854618;
RX PubMed=26930622;
WW http://www.molmeth.org/protocol/culturing-hei-oc1
CC Characteristics: Growth at the permissive (33 Celsius) temperature results in dedifferentiation of the cells and accelerated proliferation. At the restrictive temperature (39 Celsius) cell proliferation halts in about 48h.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID HEI193
AC CVCL_7670
SY HEI-193
DR BTO; BTO:0005037
DR ATCC; PTA-4544
RX PubMed=11836557;
RX PubMed=17868749;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Discontinued: ATCC; PTA-4544; true.
DI NCIt; C3269; Schwannoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HEK
AC CVCL_M624
SY Human Embryonic Kidney; HEK-1; HEK-RLV
DR BioSample; SAMN03151703
RX CelloPub=CLPUB00339;
RX PubMed=1246601;
RX PubMed=4137948;
RX PubMed=4469665;
RX PubMed=4621398;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=4469665, PubMed=20143388). Was originally thought to originate from an embryonic kidney.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Caution: Not to be confused with cell line HEK293 (CVCL_0045).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HEK 293 STF
AC CVCL_AQ26
SY STF; Super TOP-FLASH
DR ATCC; CRL-3249
RX PubMed=15035989;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK 293 Tet-Off
AC CVCL_V349
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-Off_Cell_Lines
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK 293 Tet-On 3G
AC CVCL_V350
DR BTO; BTO:0003347
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_3G_Cell_Lines
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK 293 tTS
AC CVCL_V351
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-tTS_Cell_Lines
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK/HRV
AC CVCL_M625
DR BioSample; SAMN03151704
RX PubMed=1246601;
RX PubMed=4469665;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (HEK) has been shown to be a HeLa derivative (PubMed=1246601, PubMed=4469665, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M624 ! HEK
SX Female
CA Cancer cell line
//
ID HEK-293-Munc18b
AC CVCL_GR68
SY HEK-Munc18b18
DR TOKU-E; 4146
RX PubMed=19723587;
CC Transfected with: HGNC; 11445; STXBP2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-293-TrkB
AC CVCL_9868
SY HEK-TrkB; HEK293-TrkB
DR BTO; BTO:0005025
CC Transfected with: HGNC; 8032; NTRK2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-293.2sus
AC CVCL_4W07
DR ATCC; CRL-1573.3
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-293B1
AC CVCL_W457
RX PubMed=10952671;
CC Transfected with: HGNC; 285; ADRB1.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-293B2
AC CVCL_9869
SY 293-B2; HEK293B2
DR BTO; BTO:0003468
RX PubMed=10952671;
CC Transfected with: HGNC; 286; ADRB2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-293CymR
AC CVCL_9870
SY QBI-HEK 293CymR; QBI-HEK 293-CymR; QBI-HEK293CymR; 293-CymR
DR BTO; BTO:0002732
RX PubMed=17083727;
WW http://www.my-whiteboard.com/qbiogene-q-mate-inducible-expression-system/
CC Transfected with: UniProtKB; O33453; P.putida cymR.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-3KO
AC CVCL_HB82
SY IP3R Null HEK-293
RX PubMed=27048566;
WW https://www.kerafast.com/product/2962/ip3r-expressing-hek-293-cell-lines
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6180; ITPR1.
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6181; ITPR2.
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 6182; ITPR3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue hMD2-CD14
AC CVCL_IM95
WW http://www.invivogen.com/hek-blue-hmd2-cd14
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL-12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 1628; CD14.
CC Transfected with: HGNC; 17156; LY96.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue hTLR2
AC CVCL_IM80
WW http://www.invivogen.com/hek-blue-htlr2
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 1628; CD14.
CC Transfected with: HGNC; 11848; TLR2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue hTLR3
AC CVCL_IM81
WW http://www.invivogen.com/hek-blue-htlr3
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 11849; TLR3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue hTLR4
AC CVCL_IM82
WW http://www.invivogen.com/hek-blue-htlr4
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL-12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 1628; CD14.
CC Transfected with: HGNC; 17156; LY96.
CC Transfected with: HGNC; 11850; TLR4.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue hTLR5
AC CVCL_IM83
WW http://www.invivogen.com/hek-blue-htlr5
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 11851; TLR5.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue hTLR7
AC CVCL_IM84
WW http://www.invivogen.com/hek-blue-htlr7
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 15631; TLR7.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue hTLR8
AC CVCL_IM85
WW http://www.invivogen.com/hek-blue-htlr8
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 15632; TLR8.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue hTLR9
AC CVCL_IM86
WW http://www.invivogen.com/hek-blue-htlr9
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 15633; TLR9.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue KD-TLR5
AC CVCL_5I78
WW http://www.invivogen.com/hek-blue-kd-tlr5
CC Knockout cell: Method=shRNA knockdown; HGNC; 11851; TLR5.
CC Transfected with: HGNC; 439; ALPP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue mTLR13
AC CVCL_IM94
WW http://www.invivogen.com/hek-blue-tlr13
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: MGI; MGI:3045213; Tlr13.
CC Transfected with: HGNC; 439; ALPP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue mTLR2
AC CVCL_IM87
WW http://www.invivogen.com/hek-blue-mtlr2
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: MGI; MGI:88318; Cd14.
CC Transfected with: MGI; MGI:1346060; Tlr2.
CC Transfected with: HGNC; 439; ALPP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue mTLR3
AC CVCL_IM88
WW http://www.invivogen.com/hek-blue-mtlr3
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: MGI; MGI:2156367; Tlr3.
CC Transfected with: HGNC; 439; ALPP.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue mTLR4
AC CVCL_IM89
WW http://www.invivogen.com/hek-blue-mtlr4
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: MGI; MGI:88318; Cd14.
CC Transfected with: MGI; MGI:1341909; Ly96.
CC Transfected with: MGI; MGI:96824; Tlr4.
CC Transfected with: HGNC; 439; ALPP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue mTLR5
AC CVCL_IM90
WW http://www.invivogen.com/hek-blue-mtlr5
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: MGI; MGI:1858171; Tlr5.
CC Transfected with: HGNC; 439; ALPP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue mTLR7
AC CVCL_IM91
WW http://www.invivogen.com/hek-blue-mtlr7
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: MGI; MGI:2176882; Tlr7.
CC Transfected with: HGNC; 439; ALPP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue mTLR8
AC CVCL_IM92
WW http://www.invivogen.com/hek-blue-mtlr8
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: MGI; MGI:2176887; Tlr8.
CC Transfected with: HGNC; 439; ALPP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-Blue mTLR9
AC CVCL_IM93
WW http://www.invivogen.com/hek-blue-mtlr9
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites.
CC Transfected with: MGI; MGI:1932389; Tlr9.
CC Transfected with: HGNC; 439; ALPP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-CaSR
AC CVCL_E339
SY CaSR; CaSR-HEK
WW http://www.addexbio.com/productdetail?pid=88
CC Transfected with: HGNC; 1514; CASR.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK-SC-293T
AC CVCL_4U22
DR ATCC; PTA-12593
RX Patent=US8986991;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
CC Discontinued: ATCC; PTA-12593; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID HEK-TERASB56gamma
AC CVCL_D123
SY TERV-AntiSenseB56
DR EFO; EFO_0001250
RX PubMed=14998489;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID HEK-TERST
AC CVCL_D124
SY TERV-ST
DR EFO; EFO_0001251
RX PubMed=11884599;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HEK-TERST110
AC CVCL_D125
SY TERV-ST110
DR EFO; EFO_0001252
RX PubMed=11884599;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HEK-TERV
AC CVCL_D122
SY TERV
DR EFO; EFO_0001249
RX PubMed=11884599;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HEK-TLR2
AC CVCL_IM79
DR GEO; GSM618017
DR GEO; GSM618018
DR GEO; GSM618019
DR GEO; GSM618020
DR GEO; GSM618021
DR GEO; GSM618022
DR GEO; GSM618023
DR GEO; GSM618024
DR GEO; GSM618025
DR GEO; GSM618026
DR GEO; GSM618027
DR GEO; GSM618028
DR GEO; GSM618029
DR GEO; GSM618030
DR GEO; GSM618031
DR GEO; GSM618032
DR GEO; GSM618033
DR GEO; GSM618034
DR GEO; GSM618035
DR GEO; GSM618036
RX PubMed=21220698;
CC Transfected with: HGNC; 11848; TLR2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK001
AC CVCL_3700
DR CLO; CLO_0003678
DR ATCC; CRL-2404
DR BioSample; SAMN03471835
RX PubMed=10664009;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (p1321)].
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 12,13
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HEK1.1
AC CVCL_2H48
RX PubMed=21726526;
CC Transfected with: HGNC; 10585; SCN1A.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293
AC CVCL_0045
SY Hek293; HEK-293; HEK 293; HEK;293; 293; 293 HEK; Human Embryonic Kidney 293
DR BTO; BTO:0000007
DR CLO; CLO_0001230
DR CLO; CLO_0050903
DR EFO; EFO_0001182
DR MCCL; MCC:0000006
DR CLDB; cl45
DR CLDB; cl46
DR CLDB; cl47
DR CLDB; cl7133
DR ATCC; CRL-1573
DR ATCC; PTA-4488
DR BCRC; 60019
DR BCRJ; 0009
DR BioSample; SAMN03471398
DR BioSample; SAMN03473347
DR BioSamples; SAMEA2018185
DR CCLV; CCLV-RIE 0197
DR CCRID; 3111C0001CCC000010
DR CCRID; 3111C0002000000005
DR CCRID; 3131C0001000200001
DR CCRID; 3131C0001000200018
DR ChEMBL-Cells; CHEMBL3307715
DR ChEMBL-Targets; CHEMBL614818
DR CLS; 300192/p777_HEK293
DR Cosmic; 2520629
DR DSMZ; ACC-305
DR ECACC; 85120602
DR ENCODE; ENCBS022BLS
DR ENCODE; ENCBS209KHO
DR ENCODE; ENCBS264HQL
DR ENCODE; ENCBS375ENC
DR ENCODE; ENCBS393ENC
DR ENCODE; ENCBS421ENC
DR ENCODE; ENCBS439ENC
DR ENCODE; ENCBS479AAA
DR ENCODE; ENCBS480AAA
DR ENCODE; ENCBS481AAA
DR ENCODE; ENCBS482AAA
DR ENCODE; ENCBS483AAA
DR ENCODE; ENCBS484AAA
DR ENCODE; ENCBS486AAA
DR ENCODE; ENCBS522ENC
DR ENCODE; ENCBS523ENC
DR ENCODE; ENCBS613RZL
DR ENCODE; ENCBS906GPZ
DR GEO; GSM580027
DR GEO; GSM580028
DR GEO; GSM651571
DR GEO; GSM945256
DR GEO; GSM945288
DR GEO; GSM1374525
DR ICLC; HTL03003
DR IZSLER; BS CL 129
DR JCRB; JCRB9068
DR KCB; KCB 200408YJ
DR KCB; KCB 200971YJ
DR KCLB; 21573
DR Lonza; 46
DR NCBI_Iran; C497
DR NIH-ARP; 103-306
DR PRIDE; PXD000589
DR PRIDE; PXD000623
DR PRIDE; PXD000680
DR PRIDE; PXD000933
DR PRIDE; PXD001468
DR PRIDE; PXD001511
DR PRIDE; PXD001711
DR PRIDE; PXD002389
DR PRIDE; PXD002395
DR PRIDE; PXD002601
DR PRIDE; PXD002676
DR PRIDE; PXD003700
DR PRIDE; PXD003896
DR RCB; RCB1637
DR TKG; TKG 0306
DR TOKU-E; 31
DR Wikidata; Q489618
RX PubMed=886304;
RX PubMed=21269460;
RX PubMed=21502043;
RX PubMed=22278370;
RX PubMed=23325432;
RX PubMed=24618588;
RX PubMed=25182477;
RX PubMed=25894527;
RX PubMed=25903999;
RX PubMed=27577262;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/HEK_293_cells
WW http://hek293.com/
WW http://hek293genome.org/v2/
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HEK293
WW http://www.proteinatlas.org/learn/cellines
WW http://141.61.102.20/mxdb/project/show/9191407937500
WW http://www.addexbio.com/productdetail?pid=76
WW http://fluoview.magnet.fsu.edu/gallery/cells/hek/hekcells.html
WW http://en.vircell.com/products/293-cell-line/
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-176.html
WW http://web.archive.org/web/20140910211526/http://webserver.mbi.ufl.edu/~shaw/293.html
WW http://tcpaportal.org/mclp/
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~24-30 hours (DSMZ).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Omics: Cell surface proteome.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced.
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: Methylated arginine analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using proteomics.
CC Misspelling: Occasionally 'HECK293'.
ST Source(s): ATCC; CLS; DSMZ; ECACC; JCRB; KCLB; PubMed=11416159; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14 (ATCC; CLS; DSMZ; ECACC; KCLB; PubMed=11416159; RCB)
ST D13S317: 12 (JCRB; TKG)
ST D16S539: 9,13 (ATCC; ECACC; JCRB; RCB; TKG)
ST D16S539: 9 (CLS; DSMZ)
ST D18S51: 18 (CLS)
ST D18S51: 17,18 (PubMed=11416159)
ST D21S11: 28,30.2
ST D3S1358: 15,17
ST D5S818: 8,9
ST D7S820: 11,12
ST D8S1179: 12,14
ST FGA: 23
ST Penta D: 9,10
ST Penta E: 7,15
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HEK293 (+Galpha16) AequoScreen
AC CVCL_5I96
WW http://www.perkinelmer.com/Catalog/Product/ID/ES-000-A26
CC Transfected with: UniProtKB; P07164; Aequorin.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293 482R
AC CVCL_0296
SY 482R-HEK293; HEK-293 482R; HEK 293 482R
DR MCCL; MCC:0000186
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293 AequoScreen
AC CVCL_5I97
WW http://www.perkinelmer.com/Catalog/Product/ID/ES-000-A30
CC Transfected with: UniProtKB; P07164; Aequorin.
CC Transfected with: HGNC; 4383; GNA15.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293 Cav3.1
AC CVCL_HC62
SY HEK-293 Cav3.1c; Q-31
RX PubMed=10648811;
RX PubMed=17477828;
WW https://www.kerafast.com/product/2886/low-voltage-activated-lva-t-type-ca-channel-cav3-hek293-cell-lines
CC Transfected with: HGNC; 1394; CACNA1G.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293 Cav3.2
AC CVCL_HC63
SY Hh8-5
RX PubMed=12080115;
RX PubMed=17477828;
WW https://www.kerafast.com/product/2886/low-voltage-activated-lva-t-type-ca-channel-cav3-hek293-cell-lines
CC Transfected with: HGNC; 1395; CACNA1H.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293 Cav3.3
AC CVCL_HC64
SY LT9-8
RX PubMed=12080115;
RX PubMed=17477828;
WW https://www.kerafast.com/product/2886/low-voltage-activated-lva-t-type-ca-channel-cav3-hek293-cell-lines
CC Transfected with: HGNC; 1396; CACNA1I.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-AEBP2
AC CVCL_HC69
DR ENCODE; ENCBS638MCL
DR ENCODE; ENCBS715MMR
CC Transfected with: HGNC; 24051; AEBP2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-ATF2
AC CVCL_HC70
DR ENCODE; ENCBS268PXW
DR ENCODE; ENCBS818PXJ
CC Transfected with: HGNC; 784; ATF2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-BCL11B
AC CVCL_HC71
DR ENCODE; ENCBS395FBP
DR ENCODE; ENCBS923OML
CC Transfected with: HGNC; 13222; BCL11B.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-CTCF
AC CVCL_HC72
DR ENCODE; ENCBS268XWC
DR ENCODE; ENCBS454VNJ
CC Transfected with: HGNC; 13723; CTCF.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-EGR2
AC CVCL_HC73
DR ENCODE; ENCBS738RNR
DR ENCODE; ENCBS970WCY
CC Transfected with: HGNC; 3239; EGR2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-GFI1B
AC CVCL_HC74
DR ENCODE; ENCBS320GSB
DR ENCODE; ENCBS321IHW
CC Transfected with: HGNC; 4238; GFI1B.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-GLI4
AC CVCL_HC75
DR ENCODE; ENCBS601JDX
DR ENCODE; ENCBS966YJO
CC Transfected with: HGNC; 4320; GLI4.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-GLIS1
AC CVCL_HC76
DR ENCODE; ENCBS300BBW
DR ENCODE; ENCBS695XFP
CC Transfected with: HGNC; 29525; GLIS1.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-GLIS2
AC CVCL_HC77
DR ENCODE; ENCBS101WTD
DR ENCODE; ENCBS627NYN
CC Transfected with: HGNC; 29450; GLIS2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-INSM2
AC CVCL_HC78
DR ENCODE; ENCBS121NOF
DR ENCODE; ENCBS748WVG
CC Transfected with: HGNC; 17539; INSM2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-KLF1
AC CVCL_HC79
DR ENCODE; ENCBS211CSP
DR ENCODE; ENCBS870ICB
CC Transfected with: HGNC; 6345; KLF1.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-KLF17
AC CVCL_HC80
DR ENCODE; ENCBS328EZX
DR ENCODE; ENCBS485LHG
CC Transfected with: HGNC; 18830; KLF17.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-KLF7
AC CVCL_HC81
DR ENCODE; ENCBS079LXY
DR ENCODE; ENCBS184IBZ
CC Transfected with: HGNC; 6350; KLF7.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-KLF8
AC CVCL_HC82
DR ENCODE; ENCBS132UZL
DR ENCODE; ENCBS960DYO
CC Transfected with: HGNC; 6351; KLF8.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-KLF9
AC CVCL_HC83
DR ENCODE; ENCBS321GAS
DR ENCODE; ENCBS659BWP
CC Transfected with: HGNC; 1123; KLF9.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-MAZ
AC CVCL_HC84
DR ENCODE; ENCBS099PTU
DR ENCODE; ENCBS373QTO
DR ENCODE; ENCBS541TCN
CC Transfected with: HGNC; 6914; MAZ.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-MYNN
AC CVCL_HC85
DR ENCODE; ENCBS187WDU
DR ENCODE; ENCBS898VIL
CC Transfected with: HGNC; 14955; MYNN.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-OSR2
AC CVCL_HC86
DR ENCODE; ENCBS582ZUH
DR ENCODE; ENCBS927YCP
CC Transfected with: HGNC; 15830; OSR2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-OVOL3
AC CVCL_HC87
DR ENCODE; ENCBS294AQJ
DR ENCODE; ENCBS465UQI
CC Transfected with: HGNC; 14186; OVOL3.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-PRDM1
AC CVCL_HC88
DR ENCODE; ENCBS153AXP
DR ENCODE; ENCBS830CXI
CC Transfected with: HGNC; 9346; PRDM1.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-PRDM10
AC CVCL_HC89
DR ENCODE; ENCBS002NWR
DR ENCODE; ENCBS154XJI
CC Transfected with: HGNC; 13995; PRDM10.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-PRDM12
AC CVCL_HC90
DR ENCODE; ENCBS395UVF
DR ENCODE; ENCBS568ALT
CC Transfected with: HGNC; 13997; PRDM12.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-REST
AC CVCL_HC91
DR ENCODE; ENCBS064MAI
DR ENCODE; ENCBS988LBI
CC Transfected with: HGNC; 9966; REST.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-SALL4
AC CVCL_HC92
DR ENCODE; ENCBS247KOX
CC Transfected with: HGNC; 15924; SALL4.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-SP2
AC CVCL_HC93
DR ENCODE; ENCBS525GEV
DR ENCODE; ENCBS974ABS
CC Transfected with: HGNC; 11207; SP2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-SP3
AC CVCL_HC94
DR ENCODE; ENCBS227SEC
DR ENCODE; ENCBS451MRF
CC Transfected with: HGNC; 11208; SP3.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID HEK293 eGFP-SP7
AC CVCL_HC95
DR ENCODE; ENCBS387JTD
DR ENCODE; ENCBS516AIH
DR ENCODE; ENCBS983QBQ
CC Transfected with: HGNC; 17321; SP7.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
您正在向 biovector.net 发送关于产品 细胞株Cell Lines 32-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
